II.1)
Scope of the procurement
Provision of Extended Half Life Recombinant Factor VIII
Reference number:
Blood
33141530
-
Blood coagulants
Supplies
II.1.4)
Short description
The Board of St. James’s Hospital herein known as the Contracting Authority (CA) invites applications from suitably qualified and experienced interested parties (herein known as candidates) for the provision of extended half life recombinant factor VIII 2021.
II.1.5)
Estimated total value
Value excluding VAT: 18000000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2.2)
Additional CPV code(s)
33141510
-
Blood products
33141570
-
Human blood
33194210
-
Blood-transfusion devices
33194220
-
Blood-transfusion supplies
33600000
-
Pharmaceutical products
II.2.3)
Place of performance
Main site or place of performance:
Ireland
II.2.4)
Description of the procurement
The Board of St. James’s Hospital herein known as the Contracting Authority (CA) invites applications from suitably qualified and experienced interested parties (herein known as candidates) for the provision of extended half life recombinant factor VIII 2021.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 18000000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
36
This contract is subject to renewal:
no
II.2.9)
Information about the limits on the number of candidates to be invited
Envisaged number of candidates:
3
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.12)
Information about electronic catalogues
Tenders must be presented in the form of electronic catalogues or include an electronic catalogue
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no